The recent legal victory for Novo Nordisk, which prohibits compounding pharmacies from producing cheaper, unauthorized copies of its widely recognized medications, Ozempic and Wegovy, marks a significant moment in the pharmaceutical landscape. A federal judge in Texas firmly rejected the bid of compounding pharmacies that sought to continue manufacturing these copies during ongoing legal challenges.
0 Comments
In an era where digital currencies have become increasingly prominent, the rise of the $TRUMP cryptocurrency has stirred significant controversy. Launching with a dizzying market cap of $2.7 billion, the token’s most sensational promotion promised exclusive access to President Trump himself, offering dinners and VIP tours. As enticing as these offers may seem, they mask
0 Comments